BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress

  September 9, 2025

   · 

  4 min read
• Press Releases

  Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer

  September 9, 2025

   · 

  2 min read
• Press Releases

  Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes

  September 9, 2025

   · 

  4 min read
• Press Releases

  Dizal Showcases Robust Portfolio of Lung Cancer Studies at 2025 WCLC

  September 9, 2025

   · 

  8 min read
• Press Releases

  Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

  September 9, 2025

   · 

  3 min read
• Press Releases

  AbTherx Appoints Abhi Saharia, PhD, as Chief Business Officer

  September 9, 2025

   · 

  2 min read
• Press Releases

  Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer

  September 9, 2025

   · 

  21 min read
• Press Releases

  New Data at American Foregut Society’s 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

  September 9, 2025

   · 

  6 min read
• Press Releases

  Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025

  September 9, 2025

   · 

  7 min read
• Press Releases

  Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

  September 9, 2025

   · 

  5 min read